Integrilin, Injektionslösung

7680540500111 CH-54050 Injektionslösung
Integrilin, Injektionslösung
Integrilin, Injektionslösung
Integrilin, Injektionslösung
1 / 3
google

Article details

Package size
10
Selling units
10
Measure
ml
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
27/06/2025
Summary of Product Characteristics
Français
27/06/2025
Summary of Product Characteristics
Italien
27/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
2.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.38 MG Substance HBESI

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
54050
Drug name
Integrilin, Injektionslösung
Galenic form
LSPA
ATC Code
B01AC16
Authorization status
Z
Dispensing category
A
First authorization
27/02/1997
Authorization expiration date
30/11/2025
IT Number
06.03.2.
Domain
Human medicine
Field of application
Thrombozytenaggregationshemmer

Package details

Description (FR)
INTEGRILIN sol inj 10 ml
Description (DE)
INTEGRILIN Inj Lös 10 ml
Market launch
31/01/2013
Market withdrawal
25/10/2023
Narcotic (BTM)
No